1. Home
  2. WERN vs CNTA Comparison

WERN vs CNTA Comparison

Compare WERN & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WERN
  • CNTA
  • Stock Information
  • Founded
  • WERN 1956
  • CNTA 2020
  • Country
  • WERN United States
  • CNTA United Kingdom
  • Employees
  • WERN N/A
  • CNTA N/A
  • Industry
  • WERN Trucking Freight/Courier Services
  • CNTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • WERN Industrials
  • CNTA Health Care
  • Exchange
  • WERN Nasdaq
  • CNTA Nasdaq
  • Market Cap
  • WERN 1.8B
  • CNTA 1.6B
  • IPO Year
  • WERN N/A
  • CNTA 2021
  • Fundamental
  • Price
  • WERN $27.72
  • CNTA $13.77
  • Analyst Decision
  • WERN Hold
  • CNTA Strong Buy
  • Analyst Count
  • WERN 14
  • CNTA 9
  • Target Price
  • WERN $34.57
  • CNTA $25.63
  • AVG Volume (30 Days)
  • WERN 983.5K
  • CNTA 1.0M
  • Earning Date
  • WERN 04-29-2025
  • CNTA 05-12-2025
  • Dividend Yield
  • WERN 2.03%
  • CNTA N/A
  • EPS Growth
  • WERN N/A
  • CNTA N/A
  • EPS
  • WERN 0.55
  • CNTA N/A
  • Revenue
  • WERN $3,030,258,000.00
  • CNTA N/A
  • Revenue This Year
  • WERN $3.79
  • CNTA N/A
  • Revenue Next Year
  • WERN $7.34
  • CNTA N/A
  • P/E Ratio
  • WERN $50.26
  • CNTA N/A
  • Revenue Growth
  • WERN N/A
  • CNTA N/A
  • 52 Week Low
  • WERN $26.50
  • CNTA $7.75
  • 52 Week High
  • WERN $42.48
  • CNTA $19.09
  • Technical
  • Relative Strength Index (RSI)
  • WERN 41.89
  • CNTA 53.40
  • Support Level
  • WERN $27.48
  • CNTA $11.50
  • Resistance Level
  • WERN $29.67
  • CNTA $14.05
  • Average True Range (ATR)
  • WERN 1.21
  • CNTA 0.96
  • MACD
  • WERN 0.12
  • CNTA 0.37
  • Stochastic Oscillator
  • WERN 35.97
  • CNTA 93.60

About WERN Werner Enterprises Inc.

Werner Enterprises Inc is a transportation and logistics company. The company has two reportable segments - Truckload Transportation Services and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Share on Social Networks: